Marianne Canonico

Summary

Country: France

Publications

  1. doi request reprint Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women
    Marianne Canonico
    Institut National de la Santé et de la Recherche Médicale INSERM Unit 780 U780, Cardiovascular Epidemiology Section, 16 Avenue Paul Vaillant Couturier, Villejuif Cedex, F 94807 France
    J Clin Endocrinol Metab 93:3082-7. 2008
  2. ncbi request reprint Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study
    M Canonico
    INSERM, Unit 780 Cadiovascular Epidemiology Section, Universite Paris Sud 11, IFR 69, Villejuif, France
    J Thromb Haemost 4:1259-65. 2006
  3. pmc Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
    Marianne Canonico
    INSERM Unit 780, Cardiovascular Epidemiology Section, Villejuif Cedex, France
    BMJ 336:1227-31. 2008
  4. doi request reprint Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study
    Marianne Canonico
    INSERM Unit 780, Cardiovascular Epidemiology Section, Cedex, France
    Arterioscler Thromb Vasc Biol 30:340-5. 2010
  5. ncbi request reprint Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study
    Marianne Canonico
    INSERM Unit 780, Cardiovascular Epidemiology Section, 16 Avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
    Circulation 115:840-5. 2007
  6. doi request reprint Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study)
    Marianne Canonico
    Hormones and Cardiovascular disease, Univ Paris Sud, Villejuif, France
    Clin Endocrinol (Oxf) 77:905-10. 2012
  7. doi request reprint Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
    Valérie Olié
    Hormones and Cardiovascular disease team, CEPH Centre for research in Epidemiology and Population Health, U1018, INSERM, F94807, Villejuit, France
    Menopause 18:488-93. 2011
  8. doi request reprint Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen
    Marianne Canonico
    Hormones and Cardiovascular disease, CESP Centre for researchin Epidemiology and Population Health, U1018, INSERM, Villejuif, France
    Menopause 17:1122-7. 2010
  9. doi request reprint Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
    Valérie Olié
    INSERM, CESP Centre for research in Epidemiology and Population Health, U1018, Hormones and Cardiovascular disease, Universite Paris Sud, UMRS 1018, Villejuif, France
    Curr Opin Hematol 17:457-63. 2010
  10. doi request reprint Progestogens and venous thromboembolism among postmenopausal women using hormone therapy
    Marianne Canonico
    Centre for research in Epidemiology and Population Health, U1018, Hormones and Cardiovascular disease, Villejuif, France
    Maturitas 70:354-60. 2011

Detail Information

Publications19

  1. doi request reprint Synergism between oral estrogen therapy and cytochrome P450 3A5*1 allele on the risk of venous thromboembolism among postmenopausal women
    Marianne Canonico
    Institut National de la Santé et de la Recherche Médicale INSERM Unit 780 U780, Cardiovascular Epidemiology Section, 16 Avenue Paul Vaillant Couturier, Villejuif Cedex, F 94807 France
    J Clin Endocrinol Metab 93:3082-7. 2008
    ..This effect may be modulated by the expression of cytochromes P450 3A5 (CYP3A5) and 1A2 (CYP1A2) which are involved in the hepatic metabolism of estrogens...
  2. ncbi request reprint Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study
    M Canonico
    INSERM, Unit 780 Cadiovascular Epidemiology Section, Universite Paris Sud 11, IFR 69, Villejuif, France
    J Thromb Haemost 4:1259-65. 2006
    ..However, the impact of transdermal estrogen on the association between overweight (25 kg m(-2) < BMI < or = 30 kg m(-2)) or obesity (BMI >30 kg m(-2)) and VTE risk has not been investigated...
  3. pmc Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis
    Marianne Canonico
    INSERM Unit 780, Cardiovascular Epidemiology Section, Villejuif Cedex, France
    BMJ 336:1227-31. 2008
    ..To assess the risk of venous thromboembolism in women using hormone replacement therapy by study design, characteristics of the therapy and venous thromboembolism, and clinical background...
  4. doi request reprint Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study
    Marianne Canonico
    INSERM Unit 780, Cardiovascular Epidemiology Section, Cedex, France
    Arterioscler Thromb Vasc Biol 30:340-5. 2010
    ..Although recent data showed transdermal estrogens may be safe with respect to thrombotic risk, the impact of the route of estrogen administration and concomitant progestogens is not fully established...
  5. ncbi request reprint Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study
    Marianne Canonico
    INSERM Unit 780, Cardiovascular Epidemiology Section, 16 Avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
    Circulation 115:840-5. 2007
    ..Transdermal estrogen may be safer. However, currently available data have limited the ability to investigate the wide variety of types of progestogen...
  6. doi request reprint Endogenous oestradiol as a positive correlate of plasma fibrinogen among older postmenopausal women: a population-based study (the Three-City cohort study)
    Marianne Canonico
    Hormones and Cardiovascular disease, Univ Paris Sud, Villejuif, France
    Clin Endocrinol (Oxf) 77:905-10. 2012
    ..However, whether endogenous sex steroid hormones influence the plasma fibrinogen concentrations among postmenopausal women remains unclear...
  7. doi request reprint Hormone therapy and recurrence of venous thromboembolism among postmenopausal women
    Valérie Olié
    Hormones and Cardiovascular disease team, CEPH Centre for research in Epidemiology and Population Health, U1018, INSERM, F94807, Villejuit, France
    Menopause 18:488-93. 2011
    ..However, the impact of transdermal estrogens on VTE recurrence risk has not been investigated. The aim of our study was to assess the impact of HT by route of estrogen administration on the risk of recurrent VTE...
  8. doi request reprint Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen
    Marianne Canonico
    Hormones and Cardiovascular disease, CESP Centre for researchin Epidemiology and Population Health, U1018, INSERM, Villejuif, France
    Menopause 17:1122-7. 2010
    ..However, the differential effects of progesterone and norpregnanes on hemostasis have not yet been investigated...
  9. doi request reprint Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women
    Valérie Olié
    INSERM, CESP Centre for research in Epidemiology and Population Health, U1018, Hormones and Cardiovascular disease, Universite Paris Sud, UMRS 1018, Villejuif, France
    Curr Opin Hematol 17:457-63. 2010
    ..Transdermal estrogens may be safer but early results need to be confirmed. This review provides a summary of the most recent findings regarding the VTE risk among oral versus transdermal estrogens users...
  10. doi request reprint Progestogens and venous thromboembolism among postmenopausal women using hormone therapy
    Marianne Canonico
    Centre for research in Epidemiology and Population Health, U1018, Hormones and Cardiovascular disease, Villejuif, France
    Maturitas 70:354-60. 2011
    ..In conclusion, progestogens may have differential effects on VTE risk according to the molecules and therefore represent an important potential determinant of the thrombotic risk among postmenopausal women using estrogens...
  11. doi request reprint Postmenopausal hormone therapy and venous thromboembolism
    Valérie Olié
    INSERM, CESP Centre for research in Epidemiology and Population Health, U1018, Hormones and Cardiovascular disease, F 94807 Villejuif, France
    Thromb Res 127:S26-9. 2011
    ..Because venous thromboembolism (VTE) is the main harmful effect of HT among young postmenopausal women, reducing VTE risk appears to be a relevant strategy to improve the benefit/risk profile of HT among postmenopausal women...
  12. ncbi request reprint Hormone therapy and risk of venous thromboembolism among postmenopausal women
    M Canonico
    Cardiovascular Epidemiology Team, Hopital Paul Brousse, Villejuif, Cedex, France
    Climacteric 12:76-80. 2009
    ..Individual assessment of the benefit-risk ratio is needed before initiating treatment and oral estrogens should be avoided among women at high risk for venous thromboembolism...
  13. doi request reprint Hormonal contraceptives and arterial disease: an epidemiological update
    Genevieve Plu-Bureau
    Department of Gynecology and Endocrinology, Hôpital Universitaire Paris Centre, Paris Descartes University, Paris, France
    Best Pract Res Clin Endocrinol Metab 27:35-45. 2013
    ..23 for MI risk and 0.99 for ischemic stroke). In conclusion, newer generation formulations of COCs, as well as the non-oral hormonal contraceptive, do not seem to be safer than second generation hormonal contraceptives...
  14. pmc Age at menopause, reproductive history, and venous thromboembolism risk among postmenopausal women: the Women's Health Initiative Hormone Therapy clinical trials
    Marianne Canonico
    From the 1Hormones and Cardiovascular Disease, Center for Research in Epidemiology and Population Health, Villejuif, France 2Université Paris Sud, UMRS 1018, Villejuif, France 3Paris Descartes University and Cochin Port Royal Hospital, Paris, France 4Department of Obstetrics and Gynecology, Miller School of Medicine, University of Miami, Miami, FL 5Stanford Prevention Research Center, Department of Medicine, Stanford University, Stanford, CA 6University of Washington School of Nursing, Seattle, WA and 7Division of Preventive Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA
    Menopause 21:214-20. 2014
    ....
  15. pmc High level of plasma estradiol as a new predictor of ischemic arterial disease in older postmenopausal women: the three-city cohort study
    Valérie Scarabin-Carré
    Centre for research in Epidemiology and Population Health, Inserm Unit 1018, Hormones and Cardiovascular disease, Villejuif, France V S, M C, G P B, P Y S Université Paris Sud, UMR S 1018, Villejuif, France V S, M C, P D, P Y S
    J Am Heart Assoc 1:e001388. 2012
    ..Despite evidence that estrogens may be involved in atherothrombosis, the role of endogenous sex steroid hormones in ischemic arterial disease among postmenopausal women remains uncertain...
  16. doi request reprint Hormonal contraceptives and venous thromboembolism: an epidemiological update
    Genevieve Plu-Bureau
    Department of Gynecology and Endocrinology, Hôpital Universitaires Paris Centre, Paris Descartes University, Paris, France
    Best Pract Res Clin Endocrinol Metab 27:25-34. 2013
    ..In conclusion, newer generation formulations of hormonal contraceptives, as well as the non-oral hormonal contraceptive, seem to be more thrombogenic than second generation hormonal contraceptives...
  17. doi request reprint Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study
    Marianne Canonico
    Thromb Haemost 99:246-8. 2008
  18. doi request reprint [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study]
    Marianne Canonico
    Med Sci (Paris) 24:228-31. 2008
  19. ncbi request reprint Postmenopausal hormone therapy and cardiovascular disease: an overview of main findings
    Marianne Canonico
    INSERM Unit U780, Cardiovascular Section 16, avenue Paul Vaillant Couturier, 94807 Villejuif Cedex, France
    Maturitas 54:372-9. 2006
    ..Clinical research should be continued to assist patients and clinicians in making treatment decisions on the basis of an individual's benefits and risks...